Education
About Us
Working with TipRanks
Follow Us
Cellebrite DI (CLBT)
NASDAQ:CLBT
CLBT Stock Chart & Stats
$18.49
-$0.01(-0.05%)
At close: 4:00 PM EST
$18.49
-$0.01(-0.05%)
Day’s Range― - ―
52-Week Range$13.10 - $26.30
Previous CloseN/A
Volume262.11K
Average Volume (3M)1.32M
Market Cap
$4.43B
Enterprise Value$3.53B
Total Cash (Recent Filing)$472.18M
Total Debt (Recent Filing)$22.33M
Price to Earnings (P/E)―
Beta0.90
Next Earnings
Nov 12, 2025EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.08
Shares Outstanding239,470,060
10 Day Avg. Volume1,102,388
30 Day Avg. Volume1,316,807
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue8.09
Enterprise Value/Gross Profit9.59
Enterprise Value/Ebitda48.79
Forecast
1Y Price Target
$22.17Price Target Upside19.90% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
Federal Business ReboundManagement is confident in a rebound for its U.S. federal business, with an expectation to renew a disrupted contract at double the prior rate.
Leadership StabilityShares of Cellebrite are trading up 10% after the company appointed interim CEO Tom Hogan as its permanent CEO.
Market ExpansionThe Corellium acquisition is seen as adding significant total addressable market across defense, law enforcement, and private sector customers.
Bears Say
Cut To Financial OutlookThere was a cut to CY25 ARR and Revenue, which was heavily expected by investors.
Lowered ARR OutlookThe company lowered its full-year ARR outlook by 4%.
Cellebrite DI News
CLBT FAQ
What was Cellebrite DI’s price range in the past 12 months?
Cellebrite DI lowest stock price was $13.10 and its highest was $26.30 in the past 12 months.
What is Cellebrite DI’s market cap?
Cellebrite DI’s market cap is $4.43B.
When is Cellebrite DI’s upcoming earnings report date?
Cellebrite DI’s upcoming earnings report date is Nov 12, 2025 which is in 13 days.
How were Cellebrite DI’s earnings last quarter?
Cellebrite DI released its earnings results on Aug 14, 2025. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.077 by $0.003.
Is Cellebrite DI overvalued?
According to Wall Street analysts Cellebrite DI’s price is currently Undervalued.
Does Cellebrite DI pay dividends?
Cellebrite DI does not currently pay dividends.
What is Cellebrite DI’s EPS estimate?
Cellebrite DI’s EPS estimate is 0.09.
How many shares outstanding does Cellebrite DI have?
Cellebrite DI has 239,470,060 shares outstanding.
What happened to Cellebrite DI’s price movement after its last earnings report?
Cellebrite DI reported an EPS of $0.08 in its last earnings report, beating expectations of $0.077. Following the earnings report the stock price went up 9.292%.
Which hedge fund is a major shareholder of Cellebrite DI?
Currently, no hedge funds are holding shares in CLBT
Cellebrite DI Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$22.17 (19.90% Upside)
$22.17 (19.90% Upside)
Blogger Sentiment
Neutral
CLBT Sentiment 50%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 2.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 2.3%
Last 30 Days ▼ 2.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.89%
12-Months-Change
Fundamentals
Return on Equity
-81.98%
Trailing 12-Months
Asset Growth
41.47%
Trailing 12-Months
Company Description
Cellebrite DI
Cellebrite DI (CLBT) is a global leader in digital intelligence solutions, specializing in providing tools and services for law enforcement, military, and private sector organizations to analyze and extract data from digital devices. The company operates in the fields of digital forensics and data extraction, offering a range of products that enable users to recover, analyze, and manage data from mobile devices and cloud services. Its core products include the Universal Forensic Extraction Device (UFED), which allows for comprehensive data extraction, and Analytics solutions that assist in transforming extracted data into actionable intelligence.
CLBT Company Deck
CLBT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in ARR, cloud and SaaS solutions, and the Guardian product. The acquisition of Corellium is expected to further boost innovation and market expansion. However, uncertainty in the U.S. Federal market and modest private sector performance present challenges. Despite these challenges, the company's strong financial performance and strategic initiatives contribute to an overall positive sentiment.View all CLBT earnings summariesCLBT Stock 12 Month Forecast
Average Price Target
$22.17
▲(19.90% Upside)
Technical Analysis
Ownership Overview
―
Insiders
4.46% Mutual Funds
0.06% Other Institutional Investors
93.89% Public Companies and Individual Investors